
Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related ...
Introduction Age related macular degeneration (AMD) is major cause of visual disability in elderly population globally.1 By 2040, the global prevalence of AMD is anticipated to rise to approximately 288 million individuals.2 Vision loss in AMD is primarily …